Serum HMGB1 Level is Correlated with Serum I-FABP Level in Neonatal Patients with Necrotizing Enterocolitis

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2021 Aug 22

PMID 34418984

Citations 7

Authors

Ruyahan Huo

Heng Liu

Jing Chen

Hong Sheng

Li Miao

Affiliations

Soon will be listed here.

Abstract

Background: This study aims to investigate clinical significance of HMGB1 in neonatal patients with necrotizing enterocolitis (NEC).

Methods: This observational study enrolled a total of 106 stage II-III NEC neonatal patients, who were admitted in our hospital from March 2014 to March 2019. In addition, 99 suspected NEC patients and 200 healthy controls were included. The serum levels of HMGB1, I-FABP, and inflammatory factors CRP, IL-1β, IL-6 and TNF-α were determined by enzyme-linked immunosorbent assay (ELISA). Then, the demographic data and clinical characteristics of all patients were collected. Statistical analysis was conducted to determine the correlation between HMGB1 and the clinical characteristics.

Results: No significant difference was found in the basic characteristics of NEC patients and healthy controls, except for birth weight and gestational age. The expression levels of HMGB1, I-FABP, and inflammatory factors IL-1β, IL-6 and TNF-α were significantly higher in NEC patients, when compared to healthy controls. The serum levels of HMGB1, I-FABP, IL-1β and IL-6 markedly increased in stage II-III NEC patients, when compared to stage I NEC patients. The Pearson's analysis revealed a positive correlation between HMGB1 and I-FABP, HMGB1 and IL-1β, and HMGB1 and IL-6. The ROC curve revealed that both HMGB1 and I-FABP can potentially be used as diagnostic factors for NEC. The logistic multivariate regression revealed that I-FABP, IL-1β and IL-6 are independent risk factors for mortality in neonatal NEC patients.

Conclusions: Serum HMGB1 levels are upregulated in neonatal NEC patients, and these are correlated with the patient's prognosis.

Citing Articles

Diagnostic significance of serum levels of serum amyloid A, procalcitonin, and high-mobility group box 1 in identifying necrotising enterocolitis in newborns.

Guo L, Jiang Z, Liu H, Zhang L World J Gastrointest Surg. 2024; 16(7):2003-2011.

PMID: 39087106 PMC: 11287675. DOI: 10.4240/wjgs.v16.i7.2003.

Chromatin as alarmins in necrotizing enterocolitis.

Nofi C, Prince J, Wang P, Aziz M Front Immunol. 2024; 15:1403018.

PMID: 38881893 PMC: 11176418. DOI: 10.3389/fimmu.2024.1403018.

I-FABP protein/mRNA and IL-6 as biomarkers of intestinal barrier dysfunction in neonates with necrotizing enterocolitis and SPF BALB/c mouse models.

Chen J, Yan Z, Lin Z, Fan Y, Bao X, Chen X J Int Med Res. 2024; 52(6):3000605241254788.

PMID: 38867509 PMC: 11179468. DOI: 10.1177/03000605241254788.

Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome.

Barnett R, Lewis A, Gong Q, Preston D, Frazer L, Werthammer J J Perinatol. 2023; 44(8):1125-1131.

PMID: 38151596 PMC: 11209831. DOI: 10.1038/s41372-023-01859-2.

New insights into intestinal macrophages in necrotizing enterocolitis: the multi-functional role and promising therapeutic application.

Wei J, Meng Z, Li Z, Dang D, Wu H Front Immunol. 2023; 14:1261010.

PMID: 37841247 PMC: 10568316. DOI: 10.3389/fimmu.2023.1261010.

References

Chen Y, Wu D, Sun L . Clinical Significance of High-Mobility Group Box 1 Protein (HMGB1) and Nod-Like Receptor Protein 3 (NLRP3) in Patients with Ulcerative Colitis. Med Sci Monit. 2020; 26:e919530. PMC: 6977607. DOI: 10.12659/MSM.919530. View

Neu J, Walker W . Necrotizing enterocolitis. N Engl J Med. 2011; 364(3):255-64. PMC: 3628622. DOI: 10.1056/NEJMra1005408. View

Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D . Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission. Inflamm Bowel Dis. 2016; 22(12):2886-2893. DOI: 10.1097/MIB.0000000000000938. View

Gilfillan M, Bhandari V . Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis: Clinical practice guidelines. Early Hum Dev. 2017; 105:25-33. DOI: 10.1016/j.earlhumdev.2016.12.002. View

Banupriya N, Vishnu Bhat B, Benet B, Sridhar M, Parija S . Efficacy of zinc supplementation on serum calprotectin, inflammatory cytokines and outcome in neonatal sepsis - a randomized controlled trial. J Matern Fetal Neonatal Med. 2016; 30(13):1627-1631. DOI: 10.1080/14767058.2016.1220524. View

Lin H, Su B, Chen A, Lin T, Tsai C, Yeh T . Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005; 115(1):1-4. DOI: 10.1542/peds.2004-1463. View

Chen X, Li L, Khan M, Shi L, Wang Z, Zheng F . HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Innate Immun. 2016; 22(8):696-705. DOI: 10.1177/1753425916669862. View

Cua C, Haque U, Miao Y, Backes C . Necrotizing Enterocolitis Incidence, Characteristics, and Outcomes in Neonatal Down Syndrome Patients. Am J Perinatol. 2017; 34(13):1368-1374. DOI: 10.1055/s-0037-1603688. View

Patel R, Knezevic A, Shenvi N, Hinkes M, Keene S, Roback J . Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA. 2016; 315(9):889-97. PMC: 4805423. DOI: 10.1001/jama.2016.1204. View

10.

Coufal S, Kokesova A, Tlaskalova-Hogenova H, Frybova B, Snajdauf J, Rygl M . Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease. J Immunol Res. 2020; 2020:3074313. PMC: 7072107. DOI: 10.1155/2020/3074313. View

11.

Foster J, Seth R, Cole M . Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates. Cochrane Database Syst Rev. 2016; 4:CD001816. PMC: 6464658. DOI: 10.1002/14651858.CD001816.pub3. View

12.

Walsh M, Kliegman R . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986; 33(1):179-201. PMC: 7131118. DOI: 10.1016/s0031-3955(16)34975-6. View

13.

Tian J, Liu Y, Jiang Y, Zhou H, Zhu T, Zhao X . Association of single nucleotide polymorphisms of IL23R and IL17 with necrotizing enterocolitis in premature infants. Mol Cell Biochem. 2017; 430(1-2):201-209. DOI: 10.1007/s11010-017-2972-6. View

14.

Liu X, Wang C . Melatonin alleviates circadian rhythm disruption exacerbating DSS-induced colitis by inhibiting the distribution of HMGB1 in intestinal tissues. Int Immunopharmacol. 2019; 73:108-117. DOI: 10.1016/j.intimp.2019.05.005. View

15.

Nino D, Sodhi C, Hackam D . Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol. 2016; 13(10):590-600. PMC: 5124124. DOI: 10.1038/nrgastro.2016.119. View

16.

Garg P, Hitt M, Blackshear C, Maheshwari A . Clinical determinants of postoperative outcomes in surgical necrotizing enterocolitis. J Perinatol. 2020; 40(11):1671-1678. PMC: 10308194. DOI: 10.1038/s41372-020-0728-8. View

17.

Wazea S, Wadie W, Bahgat A, El-Abhar H . Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways. Sci Rep. 2018; 8(1):5110. PMC: 5865178. DOI: 10.1038/s41598-018-23359-6. View

18.

Garg B, Sharma D, Bansal A . Biomarkers of necrotizing enterocolitis: a review of literature. J Matern Fetal Neonatal Med. 2017; 31(22):3051-3064. DOI: 10.1080/14767058.2017.1361925. View

19.

Yu R, Jiang S, Tao Y, Li P, Yin J, Zhou Q . Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-κB signaling pathways. J Cell Physiol. 2019; 234(8):13431-13438. DOI: 10.1002/jcp.28022. View